BioSmart Co.,Ltd. (KOSDAQ:038460)
South Korea · Delayed Price · Currency is KRW 4,425.00
+80.00 (1.84%)
At close: Apr 21, 2026
BioSmart Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Other Revenue | - | -0 | -0 | - | - |
| 482,776 | 484,310 | 456,164 | 391,822 | 189,183 | |
Revenue Growth (YoY) | -0.32% | 6.17% | 16.42% | 107.11% | 13.67% |
Cost of Revenue | 397,519 | 402,047 | 377,159 | 315,092 | 120,747 |
Gross Profit | 85,256 | 82,262 | 79,006 | 76,729 | 68,436 |
Selling, General & Admin | 59,480 | 58,515 | 62,452 | 61,167 | 56,114 |
Research & Development | 692.89 | 680.12 | 1,341 | 1,168 | 426.86 |
Amortization of Goodwill & Intangibles | 201.04 | 517.82 | 567.19 | 305.87 | 269.54 |
Other Operating Expenses | 497.3 | 728.38 | 705.79 | 1,023 | 696.17 |
Operating Expenses | 62,594 | 62,802 | 69,248 | 67,428 | 60,477 |
Operating Income | 22,663 | 19,460 | 9,758 | 9,302 | 7,960 |
Interest Expense | -2,857 | -4,638 | -5,962 | -4,396 | -2,041 |
Interest & Investment Income | 738.68 | 846.24 | 618.81 | 461.18 | 172.16 |
Earnings From Equity Investments | -1,359 | 2,228 | -20.7 | 321.76 | -3,042 |
Currency Exchange Gain (Loss) | 33.13 | 66.64 | -37.47 | -131.2 | -336.59 |
Other Non Operating Income (Expenses) | -6,019 | -4,565 | 3,228 | -3,657 | 1,679 |
EBT Excluding Unusual Items | 13,200 | 13,399 | 7,585 | 1,901 | 4,391 |
Gain (Loss) on Sale of Investments | 1,194 | 913.72 | 15,880 | -102.27 | 283.56 |
Gain (Loss) on Sale of Assets | 276.14 | -315.55 | -1,014 | 143.33 | -341.1 |
Asset Writedown | -149.34 | -1,896 | -1,355 | -3.29 | -3,042 |
Other Unusual Items | 203.58 | -5,041 | 82.03 | 17.27 | 49.25 |
Pretax Income | 14,724 | 7,061 | 21,178 | 1,956 | 1,341 |
Income Tax Expense | 5,738 | 6,005 | 4,998 | 3,137 | 707.1 |
Earnings From Continuing Operations | 8,986 | 1,055 | 16,179 | -1,182 | 633.8 |
Minority Interest in Earnings | 23.07 | -928.13 | 1,728 | 1,903 | 758.67 |
Net Income | 9,009 | 127.17 | 17,907 | 721.31 | 1,392 |
Net Income to Common | 9,009 | 127.17 | 17,907 | 721.31 | 1,392 |
Net Income Growth | 6984.23% | -99.29% | 2382.56% | -48.20% | - |
Shares Outstanding (Basic) | 25 | 21 | 20 | 19 | 19 |
Shares Outstanding (Diluted) | 25 | 21 | 25 | 19 | 19 |
Shares Change (YoY) | 19.40% | -16.66% | 32.48% | - | -0.79% |
EPS (Basic) | 356.00 | 6.00 | 915.15 | 37.57 | 72.53 |
EPS (Diluted) | 356.00 | 6.00 | 556.83 | 37.57 | 72.53 |
EPS Growth | 5833.33% | -98.92% | 1382.02% | -48.20% | - |
Free Cash Flow | -9,172 | -3,213 | -1,947 | 1,930 | -4,129 |
Free Cash Flow Per Share | -362.44 | -151.61 | -76.57 | 100.52 | -215.07 |
Gross Margin | 17.66% | 16.98% | 17.32% | 19.58% | 36.18% |
Operating Margin | 4.69% | 4.02% | 2.14% | 2.37% | 4.21% |
Profit Margin | 1.87% | 0.03% | 3.93% | 0.18% | 0.74% |
Free Cash Flow Margin | -1.90% | -0.66% | -0.43% | 0.49% | -2.18% |
EBITDA | 30,098 | 27,664 | 18,247 | 18,874 | 13,591 |
EBITDA Margin | 6.23% | 5.71% | 4.00% | 4.82% | 7.18% |
D&A For EBITDA | 7,435 | 8,204 | 8,490 | 9,572 | 5,632 |
EBIT | 22,663 | 19,460 | 9,758 | 9,302 | 7,960 |
EBIT Margin | 4.69% | 4.02% | 2.14% | 2.37% | 4.21% |
Effective Tax Rate | 38.97% | 85.05% | 23.60% | 160.43% | 52.73% |
Advertising Expenses | 620.02 | 948.51 | 2,704 | 2,369 | 2,597 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.